We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVVE
126
DELISTED
Nuvve Holding Corp
NVVE
$2.27M 0.04%
+6
New +$5.46M
VSTM icon
127
Verastem
VSTM
$737M
$1.7M 0.03%
166,667
– –
BIOL
128
DELISTED
Biolase, Inc.
BIOL
$1.7M 0.03%
6,990
+529
+8% +$211K
BGDE
129
Big Digital Energy Inc
BGDE
$39.9M
$1.7M 0.03%
+32,778
New +$3.16M
VGFC
130
DELISTED
The Very Good Food Company
VGFC
$1.61M 0.03%
13,100,000
– –
OPGN
131
DELISTED
OpGen, Inc
OPGN
$1.52M 0.03%
+26,500
New +$2.66M
ONCO icon
132
Onconetix
ONCO
$3.78M
$1.47M 0.03%
+5
New +$2.19M
TRVI icon
133
Trevi Therapeutics
TRVI
$2.39B
$1.33M 0.02%
864,000
+448,000
+108% +$1.47M
RMTI icon
134
Rockwell Medical
RMTI
$31.8M
$1.27M 0.02%
95,900
+75,249
+364% +$1.14M
HCTI icon
135
Healthcare Triangle
HCTI
$11.4M
$1.14M 0.02%
+21
New +$2.02M
BCTXW
136
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$1.08M 0.02%
375,000
– –
VIVO
137
VivoPower PLC
VIVO
$130M
$1.02M 0.02%
+142,176
New +$1.61M
STKH
138
Steakholder Foods
STKH
$2.55M
$967K 0.02%
413
-77
-16% -$292K
IDAI icon
139
T Stamp
IDAI
$19M
$963K 0.02%
+13,000
New +$1.36M
ELYS
140
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$943K 0.02%
1,986,000
-272,484
-12% -$173K
CUEN
141
DELISTED
Cuentas Inc. Common Stock
CUEN
$860K 0.01%
+124,878
New +$1.03M
RKDA icon
142
Arcadia Biosciences
RKDA
$1.11M
$850K 0.01%
+40,286
New +$1.37M
VQS
143
DELISTED
VIQ SOLUTIONS INC
VQS
$800K 0.01%
+1,290,663
New +$1.22M
CDAK
144
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$782K 0.01%
+1,000,000
New +$2.1M
AVGR
145
DELISTED
Avinger, Inc. Common Stock
AVGR
$768K 0.01%
+44,542
New +$987K
IVDA icon
146
Iveda Solutions
IVDA
$3.77M
$601K 0.01%
+115,658
New +$1.02M
INM icon
147
InMed Pharmaceuticals
INM
$6.99M
$593K 0.01%
4,500
+2,588
+135% +$479K
PBLA
148
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$588K 0.01%
+91
New +$1.91M
BNTC icon
149
Benitec Biopharma
BNTC
$436M
$578K 0.01%
+91,473
New +$1.16M
IMBI
150
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$488K 0.01%
762,000
-446,275
-37% -$528K
4 5
6
7 8

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.